Is auto bi-level pressure relief-PAP as effective as CPAP in OSA patients -- a pilot study?
ABPR-PAP is a promising new ventilation mode that enables effective treatment of OSA patients.
Our study suggests that presence of low immunologic reactivity (IKA<225 ng/mL) is not associated with an increased risk of CMV and BKV reactivation over the 1st 6 months after KT. However, a trend to a more pronounced drop in IKA values over time was observed in patients with viral reactivation. These preliminary results suggests that drop in IKA values within the 1st post-KT months, unlike single-time point immune function assay, may predict the risk of opportunistic viral infections.